Auto-Injector Market Analysis

Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis)

The anaphylaxis segment in the auto-injectors market is estimated to gain a robust revenue share of 35% in the coming years owing to the rising number of people with food allergies. Globally, food allergies are becoming more common owing to various causes, including, obesity, vitamin D, exposure to ambient chemicals, gut microbiota makeup, cleanliness and lack of exposure to microbiological factors, and environmental chemical exposure. Moreover, experts believe that the number of people with food allergies is expanding, as foods that are generally considered nutritious can be poisonous to someone with allergies. 

For certain people, a food allergy can cause anaphylaxis, a severe allergic reaction that happens when the immune system misinterprets a meal or substance as hazardous. This reaction can happen minutes after exposure. Additionally, anaphylaxis is a serious allergic reaction that can be fatal and, if treated right away, may usually be controlled. All these factors are expected to drive the demand for auto-injectors as they are recognized as emergency anaphylaxis therapy. For instance, more than 10 million Americans suffered from food allergies as of 2021.

Product Type (Disposable, Reusable)

Auto-injectors market from the disposable segment is set to garner a notable share. Disposable auto-injectors for prefilled syringes are simple to use and meant for patients to administer fixed-dose injections subcutaneously. Moreover, more than 60% of single-use auto-injectors are disposable and the market is expected to grow owing to the increasing adoption of innovative technologies.

Our in-depth analysis of the global market includes the following segments: